|
ARPP19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5486000000029E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.409370E-04 |
| Normal-vs-Stage2 |
3.497800E-03 |
| Normal-vs-Stage3 |
9.62199999999802E-05 |
| Normal-vs-Stage4 |
1.235590E-04 |
| Stage1-vs-Stage2 |
9.091200E-01 |
| Stage1-vs-Stage3 |
4.819400E-01 |
| Stage1-vs-Stage4 |
4.285400E-01 |
| Stage2-vs-Stage3 |
7.212200E-01 |
| Stage2-vs-Stage4 |
6.047000E-01 |
| Stage3-vs-Stage4 |
8.183200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79095999999213E-05 |
| Normal-vs-AfricanAmerican |
1.548600E-01 |
| Normal-vs-Asian |
3.158100E-03 |
| Caucasian-vs-AfricanAmerican |
1.358550E-01 |
| Caucasian-vs-Asian |
7.503400E-01 |
| AfricanAmerican-vs-Asian |
2.972400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.67859999997433E-06 |
| Normal-vs-Female |
1.445970E-04 |
| Male-vs-Female |
1.917160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.801960E-03 |
| Normal-vs-Age(41-60Yrs) |
4.31990000000493E-05 |
| Normal-vs-Age(61-80Yrs) |
1.62262999999774E-05 |
| Normal-vs-Age(81-100Yrs) |
2.700500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.709800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.232030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.339200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.165000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.684200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.528800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.093200E-01 |
| Classical-VS-Follicular |
1.198380E-01 |
| Classical-VS-Other |
2.145800E-01 |
| Classical-VS-Normal |
4.753400E-04 |
| Tall-VS-Follicular |
4.031000E-01 |
| Tall-VS-Other |
2.397800E-01 |
| Tall-VS-Normal |
1.408030E-02 |
| Follicular-VS-Other |
5.954000E-01 |
| Follicular-VS-Normal |
2.220400E-04 |
| Other-VS-Normal |
1.372210E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84901999999987E-05 |
| Normal-vs-N1 |
5.64349999999658E-05 |
| N0-vs-N1 |
5.399400E-01 |
|
|
